Johnson & Johnson EBITDA 2010-2024 | JNJ

Johnson & Johnson EBITDA for the quarter ending December 31, 2024 was $5.669B, a 25.53% decline year-over-year.

  • Johnson & Johnson 2024 EBITDA was 26.113B, a 6.23% increase from 2023.
  • Johnson & Johnson 2023 EBITDA was 24.581B, a 9.28% decline from 2022.
  • Johnson & Johnson 2022 EBITDA was 27.095B, a 1.09% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Johnson & Johnson EBITDA 2010-2024 | JNJ

  • Johnson & Johnson 2024 EBITDA was 26.113B, a 6.23% increase from 2023.
  • Johnson & Johnson 2023 EBITDA was 24.581B, a 9.28% decline from 2022.
  • Johnson & Johnson 2022 EBITDA was 27.095B, a 1.09% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B